Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Fitzgerald TraeChief Financial Officer | Grant or award | A | — 46.7K sh | Jan 21, 2026 |
| 9 | Fitzgerald TraeChief Financial Officer | Grant or award | A | — 11.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Tax withholding | F | $31K 361 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Vernon CarlaDirector | Grant or award | A | — 750 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Moore MichaelPresident | Grant or award | A | — 29.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Hoyt CaseyDirector, Chief Executive Officer | Grant or award | A | — 172.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Buss Jessica EDirector, Chief Executive Officer | Grant or award | A | — 941.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Cambre JeromeVice President of Sales | Grant or award | A | — 40.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Cambre JeromeVice President of Sales | Grant or award | A | — 10.2K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 2,224 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 9 | Trahan JeremyGeneral Counsel | Grant or award | A | — 12.6K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 363 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Smith DironEVP, Chief Financial Officer | Option exercise | M | — 1,709 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Frazier WilliamDirector, Chief Medical Officer | Grant or award | A | — 11.7K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Trahan JeremyGeneral Counsel | Grant or award | A | — 50.4K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Senn AndrewSVP, Strategy and Business Dev | Option exercise | M | — 363 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Moore MichaelPresident | Grant or award | A | — 118.8K sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Frey Anthony GeorgeSVP and Chief Revenue Officer | Tax withholding | F | $12K 610 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 9 | Frazier WilliamDirector, Chief Medical Officer | Grant or award | A | — 2,922 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 9 | Bowser Douglas SDirector | Grant or award | A | — 750 sh | Jan 21, 2026 traded Jan 19, 2026 |
| 8 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | $149K 50.0K sh | Jan 21, 2026 traded Jan 16, 2026 |
| 5 | Morrissey Michael JamesEVP, Head of Tech. Operations | Tax withholding | F | $44K 429 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 5 | Smith DironEVP, Chief Financial Officer | Tax withholding | F | $6,131 72 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 5 | Smith DironEVP, Chief Financial Officer | Option exercise | M | — 292 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 5 | Smith DironEVP, Chief Financial Officer | Option exercise | M | — 292 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 4 | Patel Rahul G.Director, See remarks below | Open-market sale · 10b5-1 plan | SELL | $89K 1,000 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 4 | Patel Rahul G.Director, See remarks below | Open-market sale · 10b5-1 plan | SELL | $84K 981 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 3 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | — 25.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 1 | Patel Rahul G.Director, See remarks below | Open-market sale · 10b5-1 plan | SELL | $26K 300 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 1 | Shafer AndrewChief Cust Mkt & Brnd Officer | Open-market sale · 10b5-1 plan | SELL | $9,940 5,000 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | $20K 1,750 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 0 | Bluestone JeffreyDirector | Option exercise · 10b5-1 plan | M | — 5,000 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 0 | Mat IshbiaDirector, President and CEO, 10% Owner | Derivative conversion · 10b5-1 plan | C | — 0 sh | Jan 21, 2026 traded Jan 16, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | — 7,317 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | — 1,750 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 0 | D'Amico AndrewDirector | Option exercise · 10b5-1 plan | M | — 200 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | Option exercise · 10b5-1 plan | M | $37K 7,317 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 0 | D'Amico AndrewDirector | Option exercise · 10b5-1 plan | M | $20K 200 sh | Jan 21, 2026 traded Jan 20, 2026 |
| 0 | Selecky ChristobelDirector | Option exercise · 10b5-1 plan | M | $75K 25.0K sh | Jan 21, 2026 traded Jan 20, 2026 |
| 61 | Manulife (Singapore) Pte. Ltd.10% Owner | NAJohn Hancock GA Senior Loan Trust Open-market purchase | BUY | $3.00M 185.8K sh | Jan 20, 2026 traded Jan 15, 2026 |